Gut bacteria and nerve pain after chemo
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how bacteria in your gut (microbiome) might be linked to nerve pain from chemotherapy. It is for people who are already in the OzoParQT trial and will provide a stool sample to help understand this connection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already taking part in the OzoParQT study (ozone therapy for nerve pain) and agree to also give a stool sample for this study.
- You are 18 years or older.
- You have had chemotherapy for any kind of cancer.
- You have numbness, tingling, or pain in your hands or feet from chemotherapy that has lasted at least 3 months.
- You have not had chemotherapy that can cause nerve damage for at least 3 months, and your cancer is stable or in remission.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether ozone treatment (a gas therapy) can help relieve numbness or tingling caused by chemotherapy. It is for people whose cancer is stable or in remission and who have had these nerve symptoms for at least 3 months.
This trial tests if adding electroacupuncture, a gentle type of acupuncture using mild electric pulses, can help relieve nerve pain, tingling, or numbness caused by chemotherapy in people with cancer.
This trial tests whether ozone therapy can reduce painful nerve damage caused by chemotherapy. It is for adults with ongoing moderate-to-severe pain in the hands or feet after chemotherapy.
This study is testing ozone therapy as a palliative treatment for people with chronic pain who haven't found relief from other options. It aims to see if adding ozone can improve pain and quality of life.
This study looks for small molecules in the blood that might predict nerve damage caused by certain chemotherapies. If you have colorectal or lung cancer and are starting a specific chemo plan, this trial could help researchers understand why some people get nerve problems and others don't.
This trial tests whether a blend of CBG and CBD oils can help relieve nerve pain, tingling, or weakness caused by platinum-based chemotherapy in people with certain gastrointestinal cancers. If you have had colorectal, biliary, pancreatic, esophageal, gastric, or small intestinal cancer and completed chemo in the last 2 years, you may be able to join.
Hear when a new Paresthesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.